HP — Helmerich and Payne Income Statement
0.000.00%
Last trade - 00:00
- $3.99bn
- $4.26bn
- $2.87bn
- 92
- 76
- 62
- 90
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,798 | 1,774 | 1,219 | 2,059 | 2,872 |
Cost of Revenue | |||||
Gross Profit | 998 | 592 | 266 | 634 | 1,159 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,778 | 2,379 | 1,647 | 2,074 | 2,311 |
Operating Profit | 20.6 | -605 | -429 | -14.8 | 562 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -51.2 | -636 | -441 | 30.9 | 593 |
Provision for Income Taxes | |||||
Net Income After Taxes | -32.5 | -496 | -337 | 6.55 | 434 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -33.7 | -494 | -326 | 6.95 | 434 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -36.8 | -497 | -328 | 5.45 | 434 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.841 | -1.48 | -2.67 | 0.273 | 4.04 |
Dividends per Share | |||||
Special Dividends per Share |